Researchers at the University of B.C. say they’ve averted a looming medical isotope shortage by proving they can produce enough of the chemical element used in life-saving cardiac and cancer scans to stop using nuclear plants.
The breakthrough research means aging nuclear power plants — plagued with leaks, high maintenance costs and problems disposing toxic waste — will likely be replaced with cyclotrons, a particle accelerator the size of an SUV, in hospitals starting as early as next year.
A team including UBC scientists has been working on finding a solution for more than five years, and TRIUMF, Canada’s national laboratory for particle and nuclear physics, announced last year that it had found an alternative by using cyclotron-based production of isotopes.
Now UBC says the cyclotron has produced enough isotopes in six hours to conduct about 500 scans — beating the previous record almost fourfold. It was the amount needed to prove that this could be a practical solution for the looming national threat of a medical isotope shortage.
The aging National Research Universal Reactor near Chalk River, Ont., is set to retire in 2016. It produces the country’s main source of medical isotopes, technetium 99m (Tc99m) — a diagnostic isotope used in medical scans.
Cyclotron-based production of Tc99m would provide a solution to shift away from reactor based production of isotopes, while providing a safe and secure supply for Canadian patients, the researchers say.
Read more: Breakthrough UBC research finds cleaner, safer source of medical isotopes than nuclear power plants
The Latest on: Medical isotopes
[google_news title=”” keyword=”Medical isotopes” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Medical isotopes
- Geology Finds a Role in Cancer Researchon May 8, 2024 at 5:02 am
Normally used to study Earth's history, hydrogen isotopes—and the techniques used to spot them—are now cluing scientists in to early signs of cancer.
- Scientists employ geology tool to detect atomic fingerprints of canceron May 7, 2024 at 9:45 am
Scientists at the University of Colorado Boulder and Princeton University have, for the first time, employed a tool often used in geology to detect the atomic fingerprints of cancer.
- Community Matters: Spreading the ‘isotopes for hope’ messageon May 4, 2024 at 12:40 am
Bruce Power is a proud member of the Canadian Nuclear Isotope Council (CNIC), a group of more than 85 members from across science, academia, health care and nuclear-sector organizations, all pulling ...
- Tweaking isotopes sheds light on promising approach to engineer semiconductorson May 3, 2024 at 9:41 am
Research led by scientists at the Department of Energy's Oak Ridge National Laboratory has demonstrated that small changes in the isotopic content of thin semiconductor materials can influence their ...
- Global Medical Isotope Market Will Grow Steadily, Driven By Increasing Demand For Nuclear Medicine Procedureson April 20, 2024 at 6:46 pm
According to SNS Insider, the Canada Medical Isotopes Market is expected to grow at a CAGR of 11.8% over the forecast period of 2024 -2031, the valuation estimated to hit $2223.99 Mn by 2031.
- ASP Isotopes: Sorting Isotopes Could Enrich Your Portfolioon April 15, 2024 at 12:12 am
ASP Isotopes is strategically positioned to tackle several critical industrial challenges through its cutting-edge proprietary technologies, Aerodynamic Separation and Quantum Laser Enrichment.
- Isotopes in Medical Investigation and Therapyon April 14, 2024 at 5:00 pm
The articles in the medical-progress series of 1941 have been published in book form (Medical Progress Annual. Volume III. 678 pp. Springfield, Illinois: Charles C Thomas Company, 1942.
- Isotopes in Medical Investigation and Therapyon April 14, 2024 at 5:00 pm
The articles in the medical-progress series of 1941 have been published in book form (Medical Progress Annual. Volume III. 678 pp. Springfield, Illinois: Charles C Thomas Company, 1942.
- B.C. medical isotope ‘trailblazer’ ARTMS fetches US$82M in Telix acquisitionon April 11, 2024 at 4:30 am
A West Coast life sciences firm known for whipping up medical isotopes has whipped up a sizeable asking price for its sale. Australia’s Telix Pharmaceuticals Ltd. announced Thursday (April 11 ...
- ASP Isotopes Issues Letter to Stockholderson April 10, 2024 at 10:00 pm
During the second half of 2023 we entered into a strategic relationship with PET Labs for the production and distribution of medical isotopes. In October 2023 we acquired 51% of PET Labs.
via Bing News